Integral Molecular, Inc.

Industry

  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
See more in Biomedtracker

Latest on Integral Molecular, Inc.

Scrip

Deal Watch: Shionogi Will Market Nxera’s Insomnia Drug In Japan

 
• By Joseph Haas, Lisa Takagi, Vibha Ravi, and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Shionogi Gets Daridorexant’s Japanese D

Scrip

Deal Watch: Coherus Terminates Immuno-Oncology Alliance With Junshi

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Coherus Ends TIGIT Pact With Junshi Des

Scrip

Deal Watch: Sanofi To Tap Owkin’s AI, Machine Learning In Oncology

 
• By Joseph Haas and Jung Won Shin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sanofi Hopes Owkin Can Aid Oncology Dis

Scrip

Asia Deal Watch: Boost For Esperion's Cholesterol Candidate As Daiichi Brought On Board

 
• By Emily Hayes, Jung Won Shin, Ian Haydock, Anju Ghangurde, and Jo Shorthouse

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Esperion Hooks Daiichi Sanky